126 related articles for article (PubMed ID: 29971561)
41. [Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application].
Zhong ZJ; Yang JX; Cao DY; Sun Y; Sun LL; Cheng XM; Chen J; Lang JH; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):196-200. PubMed ID: 22781071
[TBL] [Abstract][Full Text] [Related]
42. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
43. Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.
Nye MD; Hoyo C; Huang Z; Vidal AC; Wang F; Overcash F; Smith JS; Vasquez B; Hernandez B; Swai B; Oneko O; Mlay P; Obure J; Gammon MD; Bartlett JA; Murphy SK
PLoS One; 2013; 8(2):e56325. PubMed ID: 23418553
[TBL] [Abstract][Full Text] [Related]
44. PAX1 Methylation as a Potential Biomarker to Predict the Progression of Cervical Intraepithelial Neoplasia: A Meta-analysis of Related Studies.
Luan T; Hua Q; Liu X; Xu P; Gu Y; Qian H; Yan L; Xu X; Geng R; Zeng X; Li P
Int J Gynecol Cancer; 2017 Sep; 27(7):1480-1488. PubMed ID: 28472814
[TBL] [Abstract][Full Text] [Related]
45. Risk evaluation for the development of cervical intraepithelial neoplasia: development and validation of risk-scoring schemes.
Lee CH; Peng CY; Li RN; Chen YC; Tsai HT; Hung YH; Chan TF; Huang HL; Lai TC; Wu MT
Int J Cancer; 2015 Jan; 136(2):340-9. PubMed ID: 24841989
[TBL] [Abstract][Full Text] [Related]
46. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
[TBL] [Abstract][Full Text] [Related]
47. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
[TBL] [Abstract][Full Text] [Related]
48. Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer.
Heselmeyer-Haddad K; Sommerfeld K; White NM; Chaudhri N; Morrison LE; Palanisamy N; Wang ZY; Auer G; Steinberg W; Ried T
Am J Pathol; 2005 Apr; 166(4):1229-38. PubMed ID: 15793301
[TBL] [Abstract][Full Text] [Related]
49. The Role of
Holubekova V; Mersakova S; Grendar M; Snahnicanova Z; Kudela E; Kalman M; Lasabova Z; Danko J; Zubor P
Genet Test Mol Biomarkers; 2020 May; 24(5):256-263. PubMed ID: 32311274
[No Abstract] [Full Text] [Related]
50. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
[TBL] [Abstract][Full Text] [Related]
51. [Diagnosis and grading of cervical intraepithelial neoplasias].
Rosamilia C; Feichter G; Tzankov A; Obermann EC
Pathologe; 2012 Mar; 33(2):118-23. PubMed ID: 22350168
[TBL] [Abstract][Full Text] [Related]
52. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis.
Flatley JE; McNeir K; Balasubramani L; Tidy J; Stuart EL; Young TA; Powers HJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2782-9. PubMed ID: 19755648
[TBL] [Abstract][Full Text] [Related]
53. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes.
Guerrero-Preston R; Valle BL; Jedlicka A; Turaga N; Folawiyo O; Pirini F; Lawson F; Vergura A; Noordhuis M; Dziedzic A; Pérez G; Renehan M; Guerrero-Diaz C; De Jesus Rodríguez E; Diaz-Montes T; Rodríguez Orengo J; Méndez K; Romaguera J; Trock BJ; Florea L; Sidransky D
Cancer Prev Res (Phila); 2016 Dec; 9(12):915-924. PubMed ID: 27671338
[TBL] [Abstract][Full Text] [Related]
54. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women.
Boers A; Bosgraaf RP; van Leeuwen RW; Schuuring E; Heideman DA; Massuger LF; Verhoef VM; Bulten J; Melchers WJ; van der Zee AG; Bekkers RL; Wisman GB
Br J Cancer; 2014 Sep; 111(6):1095-101. PubMed ID: 25032730
[TBL] [Abstract][Full Text] [Related]
55. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
[TBL] [Abstract][Full Text] [Related]
56. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
[TBL] [Abstract][Full Text] [Related]
57. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
Hsu YW; Huang RL; Su PH; Chen YC; Wang HC; Liao CC; Lai HC
J Gynecol Oncol; 2017 Jul; 28(4):e56. PubMed ID: 28541643
[TBL] [Abstract][Full Text] [Related]
58. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
[TBL] [Abstract][Full Text] [Related]
59. Validation of novel DNA methylation markers in cervical precancer and cancer.
El-Zein M; Cheishvili D; Szyf M; Franco EL
Int J Cancer; 2024 Jan; 154(1):104-113. PubMed ID: 37606371
[TBL] [Abstract][Full Text] [Related]
60. [The natural history of cervical intraepithelial neoplasia I and the clinical significance of p16(INK4a) protein as a marker of progression in cervical intraepithelial neoplasia I].
Wang R; Li X; Qian M; Niu J; You Z
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):210-5. PubMed ID: 26268412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]